Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID ▲ | Title | Descriptor |
|---|---|---|---|
| 7P9L | R8APY9 | N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine-6-phosphate | |
| 7P9P | R8APY9 | N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine and AMP-PNP inhibitor | |
| 7P9Y | R8APY9 | N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine | |
| 7P7W | R8APY9 | N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine and ADP | |
| 5CL4 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing a 3-methyladenine analog or DNA containing an abasic site and a free nucleobase (71% substrate/29% product at 24 hours) | |
| 5CL5 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing a 3-methyladenine analog or DNA containing an abasic site and a free nucleobase (51% substrate/49% product at 48 hours) | |
| 5CL6 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing a 3-methyladenine analog or DNA containing an abasic site and a free nucleobase (33% substrate/67% product at 72 hours) | |
| 5CL7 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing a 3-methyladenine analog or DNA containing an abasic site and a free nucleobase (18% substrate/82% product at 96 hours) | |
| 5CL8 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing an abasic site and a free nucleobase (100% product at 144 hours) | |
| 5CL9 | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing an abasic site and a free nucleobase (100% product at 240 hours) | |
| 5CLA | R8GWR7 | Alkylpurine DNA glycosylase AlkD bound to DNA containing an abasic site and a free nucleobase (100% product at 360 hours) | |
| 6FT1 | R8KEI7 | Crystal structure of oxidised Flavodoxin 1 from Bacillus cereus (1.4 A resolution) | |
| 5D9Z | R9RL27 | Structure of Colocasia Esculenta Agglutinin with mannose bound | |
| 5H4R | R9RX81 | the complex of Glycoside Hydrolase 5 Lichenase from Caldicellulosiruptor sp. F32 E188Q mutant and cellotetraose | |
| 7QRN | R9TNA6 | Crystal structure of Ovalbumin-related protein X (OVAX) complexed with fondaparinux | |
| 4O5I | R9U684 | Crystal structure of broadly neutralizing antibody F045-092 in complex with A/Victoria/361/2011 (H3N2) influenza hemagglutinin | |
| 4O5N | R9U684 | Crystal structure of A/Victoria/361/2011 (H3N2) influenza virus hemagglutinin | |
| 4WE8 | R9U684 | The crystal structure of hemagglutinin of influenza virus A/Victoria/361/2011 | |
| 4WE9 | R9U684 | The crystal structure of hemagglutinin from influenza virus A/Victoria/361/2011 in complex with 3'SLN | |
| 4WEA | R9U684 | Structure and receptor binding prefereneces of recombinant human A(H3N2) virus hemagglutinins | |
| 8IDI | R9UQ53 | Crystal structure of nanobody VHH-T71 with MERS-CoV RBD | |
| 8IDM | R9UQ53 | Crystal structure of nanobody VHH-227 with nanobody VHH-T71 and MERS-CoV RBD | |
| 8IDO | R9UQ53 | Crystal structure of nanobody VHH-T148 with MERS-CoV RBD | |
| 8IFN | R9UQ53 | MERS-CoV spike trimer in complex with nanobody VHH-T148 | |
| 8YSH | R9UQ53 | MERS-CoV RBD in complex with nanobody Nb14 | |
| 8IWD | R9W5L0 | Aspergillus niger Rha-2 | |
| 8IWF | R9W5L0 | Aspergillus niger Rha-2 and pNPR | |
| 5XRT | R9XUW5 | Crystal structure of A/Minnesota/11/2010 (H3N2) influenza virus hemagglutinin | |
| 1FYT | RWHUAC | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
| 1J8H | RWHUAC | Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide, and MHC Class II Molecule, HLA-DR4 | |
| 3WCT | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
| 3WCU | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
| 3WCV | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
| 3WCW | S0BAP9 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form | |
| 7VLC | S0BAP9 | Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation | |
| 7VLD | S0BAP9 | Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation | |
| 7VLE | S0BAP9 | Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation | |
| 7VLF | S0BAP9 | Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation | |
| 3WCT | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
| 3WCU | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
| 3WCV | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
| 3WCW | S0BBR6 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form | |
| 7VLC | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 78% oxygen saturation | |
| 7VLD | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 69% oxygen saturation | |
| 7VLE | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 55% oxygen saturation | |
| 7VLF | S0BBR6 | Oxy-deoxy intermediate of V2 hemoglobin at 26% oxygen saturation | |
| 3WCT | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Oxygenated form | |
| 3WCU | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: Deoxygenated form | |
| 3WCV | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: CA bound form | |
| 3WCW | S0BBU7 | The structure of a deoxygenated 400 kda hemoglobin provides a more accurate description of the cooperative mechanism of giant hemoglobins: MG bound form |
